My watch list  

7 Current news of Clariant

matching the following criteria

Clariant adds polyetheramines to Industrial & Consumer Specialities chemicals range


Increasing demand has lead Clariant to add polyetheramines to its range of industrial and consumer speciality products. A new reactor in the company’s nitril-amine plant in Gendorf, Germany, has just started production to facilitate the portfolio extension. Polyetheramines are used in a variety ...


Clariant sells Custom Manufacturing Business to International Chemical Investors Group


Clariant announced the sale of its Custom Manufacturing Business to International Chemical Investors Group (ICIG) for an undisclosed transaction value. The sale is the latest step in Clariant's strategy to focus on its core competencies in colors, surfaces and performance chemicals. Clariant's ...


Clariant's Pharmaceutical Fine Chemicals is now 'Archimica'

Separation from Clariant Complete, Headquarter in Germany


The organization formerly known as the Pharmaceutical Fine Chemicals business of Clariant is now Archimica -- the world's leading global fine chemicals business focused solely on commercialization solutions for the pharmaceutical industry. The new business is comprised of virtually all assets ...


Clariant sells Pharmaceutical Fine Chemicals to TowerBrook Capital Partners


Clariant announced the sale of its Pharmaceutical Fine Chemicals unit to TowerBrook Capital Partners, L.P. for a transaction value of approximately CHF 110 million. The sale marks a further step in Clariant's strategy to focus its portfolio on core activities. The unit manufactures building ...


Clariant completes sale of Electronic Materials, Lancaster Synthesis and SF-Chem


After approval of all relevant authorities, Clariant has completed the sale of its AZ Electronic Materials business unit to The Carlyle Group, the sale of its worldwide business of Lancaster Synthesis Limited to Johnson Matthey Plc as well as the sale of its 25% minority stake in SF-Chem to ...


Clariant sells its stake in SF-Chem for CHF 22 Million


Clariant has sold its 25% stake in SF-Chem, based in Pratteln, Switzerland, to Capvis, a Swiss based Private Equity company, and to the company management for CHF 22 million. The Basel-based agrochemical company Syngenta, which owns the remaining 75% of SF-Chem, is also selling its stake to ...


Federal jury rules that Clariant does not infringe patent


A jury in Delaware found on February 2, 2001 that Clariant Life Science Molecules (Italia), SpA, does not infringe a patent owned by Great Lakes Chemical. Clariant Life Science Molecules (Italia), SpA, which was formerly known as "Archimica", is pleased with the decision of the jury in finding ...


Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE